GDF2 and metabolic dysfunction-associated steatotic liver disease: BMP9 has also been shown to suppress NAFLD, reduce obesity, improve glucose metabolism, alleviate hepatic steatosis, and decrease inflammation by reducing the promoter chromatin accessibility of Cers6, Fabp4, Fos, and Tlr1 [104].